FactSet Research Systems (FDS) maintains a robust, asset-light financial data and software subscription business, serving institutional investors with high-value analytics and proprietary data, underpinned by over 40 years of revenue growth and 27 consecutive dividend increases. The company demonstrates strong profitability, with a five-year average ROE of 37.1% and net margin of 23.7%, supported by consistent high-single-digit revenue and EPS growth, even after the 2022 CUSIP Global Services acquisition. Despite competitive pressures and potential AI-driven data commoditization, FDS exhibits a healthy balance sheet and analysts forecast continued 9% EPS CAGR. Trading at a P/E of 26.2, significantly below its five-year average, and with an average analyst fair value suggesting approximately 19% undervaluation, the stock presents an attractive entry point for long-term investors seeking a high-quality compounder.
FactSet Research Systems (FDS) operates a highly durable, asset-light business model centered on high-value subscription services for financial data and analytics. The company's strength is evidenced by its 44 consecutive years of revenue growth and its status as a Dividend Aristocrat with 27 straight years of dividend increases. Historically, FDS has delivered robust performance, growing revenue at a 9.2% CAGR and EPS at a 10.4% CAGR from FY 2015 to FY 2024, a period that includes the strategic acquisition of CUSIP Global Services (CGS). This acquisition has fortified its data moat and opened new growth avenues in private markets, partially de-risking the business from the secular trend of passive asset management. Profitability remains outstanding, with a five-year average return on equity of 37.1% and a net margin of 23.7%. Despite taking on debt for the CGS purchase, the balance sheet is solid with an interest coverage ratio over 10, and long-term debt has been reduced by 20% from its 2022 peak. Looking forward, professional forecasts anticipate a 9% EPS CAGR over the next three years, aligning with FactSet's own guidance. The stock has experienced significant valuation compression, trading at a P/E of 26.2, well below its five-year average of 35.1, following a 25% decline from recent highs. An average of analyst valuations suggests the stock may be undervalued by approximately 19%, presenting a disconnect between its consistent operational performance and current market price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment